ArticleJournal of controlled release : official journal of the Controlled Release Society2021

PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance.

Peter Y Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.